TOPIC
Biomedicine: Companies
+ FOLLOW
Related Topics:
Biomedicine: Companies
Biomedicine: Policy
Biomedicine: Science
Biomedicine: Industry Trends
Biomedicine: Geopolitics
Biomedicine: Companies
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
SHOW FULL PROFILE
Biomedicine: Geopolitics
Hutchmed weighs cancer drug’s supply-chain options amid trade war
Blood-cancer medicine, manufactured in the US, won conditional approval for sale in mainland China last month.
14 Apr 2025 - 5:02PM
videocam
New medical drugs
Trump’s tariffs: will Chinese pharmaceutical industry feel the pain?
12 Apr 2025 - 11:33AM
videocam
6
Biomedicine: Geopolitics
US report highlights China’s biotech rise, urges action to boost local industry
10 Apr 2025 - 3:28PM
4
Biomedicine: Industry Trends
China’s biotech firms record surge in overseas licensing deals in first quarter
Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion.
4 Apr 2025 - 7:00AM
Science
What if curing cancer could cost 99% less in China?
Chinese biotech start-ups are going up against Western drug makers – and they could win.
29 Mar 2025 - 8:40AM
videocam
38
United States
Chinese drug maker Akeso hailed as biotech’s ‘DeepSeek moment’ amid US rivalry
Akeso’s immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening.
16 Mar 2025 - 7:00AM
18
Advertisement
Advertisement
Advertisement
Cancer
Groundbreaking cancer therapies are the goal for this biotech innovator
PostMag talks to 5 women innovators at the top of their game and pushing the boundaries of scientific discovery: here we meet Gina Jiang, managing director of the Hong Kong Institute of Biotechnology.
12 Mar 2025 - 5:44PM
Artificial intelligence
AI-driven blood analysis may be the key to unlocking cancer’s secrets
AI helps researchers recognise patterns in the gene fragments they find in blood plasma, sparking a revolution in the field of epigenetics.
23 Feb 2025 - 11:30AM
videocam
China technology
Opinion
|
In tech war, China is gunning for mass adoption over premium innovation
From artificial intelligence and biotech to autonomous driving, China is disrupting the traditional high-cost model of proprietary innovation.
20 Feb 2025 - 9:27AM
videocam
Biomedicine: Industry Trends
Hong Kong biotech start-up Alephoson eyes global trial for eye-drug delivery
Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.
10 Feb 2025 - 9:30AM
US-China relations
US can keep edge over China aviation by staying integrated with it: expert
Testimony in advisory body hearing also heard stark warnings about China’s biotechnology advances.
7 Feb 2025 - 5:04AM
videocam
New medical drugs
ClouDr shares rise on DeepSeek integration with medical AI platform
Chinese company says DeepSeek’s AI model will enhance data mining in its platform, delivering efficiency to hospitals and pharmacies.
6 Feb 2025 - 4:22PM
videocam
Biomedicine: Industry Trends
Chinese biotech firms cash in on promising drug discoveries via licensing
China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.
7 Feb 2025 - 5:45PM
videocam
Artificial intelligence
Video
|
AI-driven firm aims to transform drug discovery
Chief scientific officer at XtalPi says AI can cut average drug discovery times to one to two years
20 Jan 2025 - 4:44PM
01:10
Artificial intelligence
AI-driven drug discovery aided by Greater Bay Area integration, firm says
XtalPi says AI is reducing drug discovery times to two years from four.
20 Jan 2025 - 4:55PM
videocam
Biomedicine: Science
CR Pharma, NAMI join forces to fight Alzheimer’s with Pfizer cancer drug
Palbociclib, developed by Pfizer for certain types of advanced breast cancer, was approved for sale in 2015.
15 Jan 2025 - 7:00AM
US-China relations
China’s WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom
US passed Biosecure Act which would ban federal contracts with targeted firms and their business partners. Legislation explicitly names WuXi.
7 Jan 2025 - 3:36AM
Advertisement
Advertisement
Advertisement
New medical drugs
Novel drug awaits Hong Kong diabetics suffering from debilitating eye disease
Oculis’ OCS-01 eye drops, currently in phase 3 trials for diabetic macular edema, can be an alternative to injection, CEO says.
16 Dec 2024 - 9:07AM
videocam
Wuxi AppTec
WuXi AppTec, WuXi Biologics surge on slimmer chances of Biosecure Act’s passage
The bill’s absence from the proposed amendments to the US National Defence Authorisation Act comes as a reprieve for the two biotech firms.
9 Dec 2024 - 2:40PM
Biomedicine: Science
Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds
About 52 per cent of Hong Kong respondents said they were willing to get the updated vaccine, compared with 58 per cent in Singapore.
4 Dec 2024 - 8:22PM
Biomedicine: Industry Trends
China welcomes new US$1 billion Sanofi project in Beijing
Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.
3 Dec 2024 - 8:00PM
Biomedicine: Science
Hong Kong start-up eyes global pest control market with scent-based products
Plasticvore is a two-year old biotech start-up offering alternative, humane solutions to controlling and eliminating pests, founder says.
1 Dec 2024 - 12:00PM
videocam
Health & Fitness
China expands health insurance coverage with 91 new drugs, innovative treatments
The health authority shows its support for novel drugs, while driving tough bargains with pharmaceutical firms on prices.
29 Nov 2024 - 4:42PM
videocam
SCMP Highlights
Recap
|
‘Promising’ steps to HIV vaccine, Trump tariffs threaten profits: 5 biotech stories
Discover breakthroughs in the biotech world, from a potential HIV cure to China’s booming drug market and innovative coronavirus treatments, in some of our latest stories.
22 Nov 2024 - 4:10PM
Biomedicine: Geopolitics
Chinese biotech firms brace for Trump tariffs, US funding bill
Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.
22 Nov 2024 - 7:30AM
Hong Kong
Vaccine shows promise in curing HIV, Hong Kong start-up says
‘We may be on the brink of a breakthrough,’ Dr Edward Leong, advisory board chairman of Immuno Cure says.
13 Jan 2025 - 2:21PM
Biomedicine: Science
Germany’s BioNTech buys Biotheus in US$800 million push into cancer drugs
BioNTech says deal will support its push into the development of cancer drugs using its proven mRNA technology.
14 Nov 2024 - 11:57AM
Science
Opinion
|
Why a new approach to diabetes treatment is desperately needed
Current widely used treatment approaches are not fit for task as they ignore the idiosyncrasies in diabetes that can arise in each patient.
12 Nov 2024 - 9:30AM
videocam
Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement